Foundation Medicine Launches FoundationOne®MRD, First-of-Its-Kind Molecular Residual Disease Test to Combine Structural Variants and Digital PCR

BOSTON--(BUSINESS WIRE)--Foundation Medicine launches FoundationOne®MRD, a molecular residual disease (MRD) test.